Engineered liposomes mediated approach for targeted colorectal cancer drug Delivery: A review

Colorectal cancer (CRC) continues to be one of the most prevalent and deadliest forms of cancer worldwide, despite notable advancements in its management. The prognosis for metastatic CRC remains discouraging, with a relative 5-year survival rate for stage IV CRC patients. Conventional treatments fo...

Full description

Bibliographic Details
Published in:International Journal of Pharmaceutics
Main Author: Shazleen Ibrahim I.; Starlin Chellathurai M.; Mahmood S.; Hakim Azmi A.; Harun N.; Ulul Ilmie Ahmad Nazri M.; Muzamir Mahat M.; Mohamed Sofian Z.
Format: Review
Language:English
Published: Elsevier B.V. 2024
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85181882337&doi=10.1016%2fj.ijpharm.2023.123735&partnerID=40&md5=a6c0fe8ff883fc14b62d5c95d8a58466

Similar Items